UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059169 |
|---|---|
| Receipt number | R000067678 |
| Scientific Title | Lung Cancer Genomic Screening Project for Individualized Medicine in Asia |
| Date of disclosure of the study information | 2025/09/23 |
| Last modified on | 2025/09/23 17:23:50 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
Acronym
LC-SCRUM-Asia
Scientific Title
Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
Scientific Title:Acronym
LC-SCRUM-Asia
Region
| Japan |
Condition
Condition
Lung cancer
Classification by specialty
| Pneumology |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
To elucidate the clinicopathological and molecular biological characteristics of lung cancer with genetic abnormalities and altered protein expression.
Basic objectives2
Others
Basic objectives -Others
To promote the development of targeted therapies and diagnostic agents by sharing analytical and clinical data with participating research institutions (including both academic and pharmaceutical organizations).
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
To characterize the clinicopathological and molecular biological features of lung cancer with genetic alterations identified in the genomic screening
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Patients aged 16 years or older
2) Patients with pathologically (histology or cytology) confirmed non-small cell or small cell lung cancer
3) Patients with cancer of clinical stage III or higher, or postoperative recurrence
4) Patients who have not received any drug treatments or have a history of two or less drug regimens for lung cancer (Patients with a history of three or more drug regimens are not eligible. However, preoperative/postoperative adjuvant chemotherapy is not included in the calculation of the number of regimens)
5) Eastern Cooperative Oncology Group performance status (PS) of 0 or 1
6) Patients who meet the following criteria for major organ function (assessed by a test performed within 2 weeks prior to study enrollment):
i) Neutrophil count : >=1500/mm3
ii) Hemoglobin : >=8.0 g/dl
iii) Platelet count : >=7.5 x 104/mm3
iv) AST, ALT : <=ULN (upper limit of normal) x 2.5 (x 5 in patients with liver metastasis)
v) Total bilirubin : <=ULN x 1.5
7) Patients without serious complications (e.g., interstitial pneumonitis, poorly controlled diabetes mellitus, cardiac disease, infection, etc.)
8) Patients who are expected to live for at least 3 months from the date of study enrollment
9) Patients who are able to submit samples that can be used for genetic analyses. The samples must be ones collected before the initial drug treatment
10) Patients who wish to enroll in genotype-directed clinical trials if the target gene alterations are identified in this study
11) Patients who have provided written consent to enroll in this study
Key exclusion criteria
none
Target sample size
5000
Research contact person
Name of lead principal investigator
| 1st name | Koichi |
| Middle name | |
| Last name | Goto |
Organization
National Cancer Center Hospital East
Division name
Department of Thoracic Oncology
Zip code
277-8577
Address
6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan
TEL
04-7133-1111
kgoto@east.ncc.go.jp
Public contact
Name of contact person
| 1st name | Hiroki |
| Middle name | |
| Last name | Izumi |
Organization
National Cancer Center Hospital East
Division name
Department of Thoracic Oncology
Zip code
277-8577
Address
6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan
TEL
04-7133-1111
Homepage URL
hiroizum@east.ncc.go.jp
Sponsor or person
Institute
National Cancer Center
Institute
Department
Personal name
Funding Source
Organization
AMED
Organization
Division
Category of Funding Organization
Government offices of other countries
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Cancer Center Hospital East
Address
6-5-1, Kashiwanoha, Kashiwa, Chiba
Tel
04-7133-111
irst@ml.res.ncc.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 09 | Month | 23 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2024 | Year | 01 | Month | 31 | Day |
Date of IRB
| 2024 | Year | 06 | Month | 20 | Day |
Anticipated trial start date
| 2024 | Year | 06 | Month | 27 | Day |
Last follow-up date
| 2044 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study is a prospective observational study.
Management information
Registered date
| 2025 | Year | 09 | Month | 23 | Day |
Last modified on
| 2025 | Year | 09 | Month | 23 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067678
